zenodoopen

Figure 2 from: Zheleva-Kyuchukova I, Gelev V (2020) Antiplatelet therapy after PCI in patients with high risk of bleeding. Pharmacia 67(3): 135-143. https://doi.org/10.3897/pharmacia.67.e52737

Figure 2 Algorithm for the duration of DAPT in patients with HBR and stable coronary disease according to the recommendations of the European Society of Cardiology (ESC) for DAPT from 2017. Abbreviations: ASA – acetylsalicylic acid; DAPT – dual antiplatelet therapy; mo – months.

ShareScore

28/100

Overall dataset sharing score

Score breakdown

These five areas show where the dataset supports — or may limit — practical reuse.

Stewardship: 8
Harmonization: 4
Access: 16
Reuse readiness: 0
Engagement: 0

Topics

percutaneous coronary interventions (PCI) dual antiplatelet therapy (DAPT) high bleeding risk (HBR) acetylsalicylic acid (ASA)